U.S. federal trademark · Serial No. 88984193 · Reg. No. 6815686
Pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations, namely, a drug formulation comprising nanoparticles of sirolimus and albumin for use in oncology; pharmaceutical preparations for the treatment of physiological diseases
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.